Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE

v3.24.1.1.u2
NET LOSS PER SHARE
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
NET LOSS PER SHARE NET LOSS PER SHARE
The table below sets forth a reconciliation of the basic and diluted earnings per share (“EPS”) calculations for the three months ended March 31, 2024 and 2023:

Three Months Ended March 31,
($ in thousands, except share and per share amounts) 2024 2023
Numerator:
Net loss $ (17,587) $ (18,490)
Denominator:
Weighted average shares outstanding - basic 94,960,371  76,524,735
Effect of dilutive equity awards (1)
  — 
Weighted average shares outstanding - diluted 94,960,371  76,524,735 
Net loss per share:
Basic $ (0.19) $ (0.24)
Diluted $ (0.19) $ (0.24)

(1) Due to the Company’s net loss, all unvested equity awards and the private placement warrants are anti-dilutive. The dilutive convertible instruments of the Backstop Notes are out of the money.

In determining the weighted average shares outstanding for the three months ended March 31, 2024 for both basic and diluted earnings per share, the Company included the Penny Warrants issued to Searchlight in transactions dated November 15, 2023 and December 13, 2023, as the common shares of stock that would be issuable upon the exercise of the warrants are issuable for nominal consideration of one cent per share of common stock or cashless exercise at the option of Searchlight. These warrants were exercisable immediately upon issuance, although no warrants had been exercised as of March 31, 2024.

Set forth in the table below is the number of securities not included in the computation of diluted shares outstanding because the effect would be anti-dilutive:
Three Months Ended March 31,
2024 2023
Grants of RSUs with service only (i.e., time-vesting) conditions 5,186,091  4,529,117 
Common stock issuable under the Backstop Notes 9,600,031  9,600,031 
Private placement warrants
272,779  272,779 

Unvested restricted stock units with both “time and performance conditions” and / or “time and market conditions” are excluded from the disclosure of the number of potentially anti-dilutive securities because neither the performance nor market conditions were met at the end of the reporting periods. Therefore, these securities are not considered to be contingently issuable for purposes of dilutive EPS or anti-dilution calculations.